UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Developing anti-helminth vaccines for people and cattle: (For)seeing the one health approach in action

One health, 2023-12, Vol.17, p.100616, Article 100616

2023

Link zum Volltext

Verfügbarkeit prüfen

Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine

Tropical medicine and infectious disease, 2018-11, Vol.3 (4), p.121

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction: Tendler, M., et al. Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine. Trop. Med. Infect. Dis. 2018, 3 , 121

Tropical medicine and infectious disease, 2019-01, Vol.4 (1), p.16

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen

Memórias do Instituto Oswaldo Cruz, 2010-08, Vol.105 (5), p.698-705

2010

Link zum Volltext

Verfügbarkeit prüfen

Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant

Frontiers in immunology, 2015-05, Vol.6, p.218-218

2015

Link zum Volltext

Verfügbarkeit prüfen

Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults

Vaccine, 2016-01, Vol.34 (4), p.586-594

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetic Variability Analysis among Clinical Candida spp. Isolates Using Random Amplified Polymorphic DNA

Memórias do Instituto Oswaldo Cruz, 2004-03, Vol.99 (2), p.147-152

2004

Link zum Volltext

Verfügbarkeit prüfen

The biotechnology-value chain: Development of Sm14 as a schistosomiasis vaccine

Acta tropica, 2008-11, Vol.108 (2), p.263-266

2008

Link zum Volltext

Verfügbarkeit prüfen

Current status of the Sm14/GLA-SE schistosomiasis vaccine: Overcoming barriers and paradigms towards the first anti-parasitic human(itarian) vaccine

Tropical medicine and infectious disease, 2018-12, Vol.3 (4), p.1-10

2018

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Sm14 Related Components in Different Helminths by Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis and Western Blotting Analysis

Memórias do Instituto Oswaldo Cruz, 2002-01, Vol.97 (s1), p.115-116

2002

Link zum Volltext

Verfügbarkeit prüfen

Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: Structural and functional characterization of a vaccine candidate

Biochimica et biophysica acta, 2009-04, Vol.1794 (4), p.655-662

2009

Link zum Volltext

Verfügbarkeit prüfen

Sm14 of Schistosoma mansoni in Fusion with Tetanus Toxin Fragment C Induces Immunoprotection against Tetanus and Schistosomiasis in Mice

Infection and Immunity, 2004-10, Vol.72 (10), p.5931-5937

2004

Link zum Volltext

Verfügbarkeit prüfen

r-Sm14 - pRSETA Efficacy in Experimental Animals

Memórias do Instituto Oswaldo Cruz, 2001-01, Vol.96 (s1), p.131-135

2001

Link zum Volltext

Verfügbarkeit prüfen

The biotechnology-value chain : Development of Sm14 as a schistosomiasis vaccine: Schisto Research Brazil

Acta tropica, 2008, Vol.108 (2-3), p.263-266

2008

Link zum Volltext

Verfügbarkeit prüfen

Foreword

Memórias do Instituto Oswaldo Cruz, 2001-09, Vol.96 (suppl), p.5-5

Tendler, Miriam

2001

Link zum Volltext

Verfügbarkeit prüfen

Foreword

Memórias do Instituto Oswaldo Cruz, 2001-09, Vol.96 (suppl), p.5-5

Tendler, Miriam

2001

Link zum Volltext

Verfügbarkeit prüfen

Preliminary Analysis of Sm14 in Distinct Fractions of Schistosoma mansoni Adult Worm Extract

Memórias do Instituto Oswaldo Cruz, 2001-01, Vol.96 (s1), p.79-83

2001

Link zum Volltext

Verfügbarkeit prüfen

Vaccination Against Schistosomiasis and Fascioliasis with the New Recombinant Antigen Sm14: Potential Basis of a Multi-Valent Anti-Helminth Vaccine?

Memorias do Instituto Oswaldo Cruz [MEM. INST. OSWALDO CRUZ]. Vol. 90, no. 2. 1995, 1995-04, Vol.90 (2), p.255-256

1995

Link zum Volltext

Verfügbarkeit prüfen

An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis

Vaccine, 2003-12, Vol.22 (1), p.137-144

2003

Link zum Volltext

Verfügbarkeit prüfen

A Schistosoma mansoni Fatty Acid-Binding Protein, Sm14, is the Potential Basis of a Dual-Purpose Anti-Helminth Vaccine

Proceedings of the National Academy of Sciences - PNAS, 1996-01, Vol.93 (1), p.269-273

1996

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Mycobacterium bovis BCG Expressing the Sm14 Antigen of Schistosoma mansoni Protects Mice from Cercarial Challenge

Infection and Immunity, 2004-06, Vol.72 (6), p.3336-3343

2004

Link zum Volltext

Verfügbarkeit prüfen

Contrasting genomic variability between clones from field isolates and laboratory populations of Schistosoma mansoni

Memórias do Instituto Oswaldo Cruz, 1997-05, Vol.92 (3), p.409-414

1997

Link zum Volltext

Verfügbarkeit prüfen

Schistosoma mansoni: protective antigens

Memórias do Instituto Oswaldo Cruz, 1987, Vol.82 Suppl 4 (suppl 4), p.125-128

Tendler, M

1987

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(57)
Portugiesisch
(19)

Erscheinungsjahr

n.n

Thema

Animals
(32)
Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Parasitology
(25)
Tropical Medicine
(21)
Schistosoma Mansoni
(20)
Schistosoma Mansoni - Immunology
(18)
Mice
(16)
Infectious Diseases
(14)
Biological And Medical Sciences
(12)
Male
(12)
Schistosomiasis Mansoni - Prevention & Control
(12)
Antigens, Helminth - Immunology
(11)
Helminth Proteins - Immunology
(11)
Schistosomiasis
(11)
Fatty Acid Transport Proteins
(10)
Immunology
(10)
Medical Sciences
(10)
Parasitic Diseases
(10)
Antigens
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Developing anti-helminth vaccines for people and cattle: (For)seeing the one health approach in action

Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women

Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine

Correction: Tendler, M., et al. Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine. Trop. Med. Infect. Dis. 2018, 3 , 121

Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen

Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant

Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults

Vaccine value profile for schistosomiasis

Genetic Variability Analysis among Clinical Candida spp. Isolates Using Random Amplified Polymorphic DNA

The biotechnology-value chain: Development of Sm14 as a schistosomiasis vaccine

Current status of the Sm14/GLA-SE schistosomiasis vaccine: Overcoming barriers and paradigms towards the first anti-parasitic human(itarian) vaccine

Characterization of Sm14 Related Components in Different Helminths by Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis and Western Blotting Analysis

Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: Structural and functional characterization of a vaccine candidate

Sm14 of Schistosoma mansoni in Fusion with Tetanus Toxin Fragment C Induces Immunoprotection against Tetanus and Schistosomiasis in Mice

r-Sm14 - pRSETA Efficacy in Experimental Animals

The biotechnology-value chain : Development of Sm14 as a schistosomiasis vaccine: Schisto Research Brazil

Foreword

Foreword

Preliminary Analysis of Sm14 in Distinct Fractions of Schistosoma mansoni Adult Worm Extract

Vaccination Against Schistosomiasis and Fascioliasis with the New Recombinant Antigen Sm14: Potential Basis of a Multi-Valent Anti-Helminth Vaccine?

An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis

A Schistosoma mansoni Fatty Acid-Binding Protein, Sm14, is the Potential Basis of a Dual-Purpose Anti-Helminth Vaccine

Recombinant Mycobacterium bovis BCG Expressing the Sm14 Antigen of Schistosoma mansoni Protects Mice from Cercarial Challenge

Contrasting genomic variability between clones from field isolates and laboratory populations of Schistosoma mansoni

Schistosoma mansoni: protective antigens

Suchergebnisse filtern